Analytical

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market, with an emphasis on the European region. Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development. Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda. Each year, TIDES’ scientific agenda includes 150+ of the industry’s top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products. 

The American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organization for pathologists and laboratory professionals. With more than 100,000 members, the society’s influence has guided the application and evolution of the pathology and laboratory medicine specialty since 1922. The pre-eminent event for the entire laboratory team, the ASCP Annual Meeting is known for bringing together pathologists, laboratory professionals, pathology residents, and more, in a learning-focused setting you can only find once per year.

The leading event to ensure CMC, regulatory success and expedited product approval.

With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access.  Topics are curated to addresses the biggest bottlenecks in cell and gene therapy development.

A two-day event with dedicated streams on the latest tools and technologies for advanced understanding of cell-based products, including optimised cell line development, strategies to overcome bottlenecks and improved efficacy and safety of cell and gene therapies to ensure clinical and commercial product success.

Connecting global pharma, biotech and academia for high-level discussions on the latest innovations in biologics development. Consisting of the Proteins & Antibodies Congress, Bispecifics in Discovery & Development Congress and Peptides & Oligonucleotides Congress, visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the biologics industry in the future.

This year’s event will feature world-renowned speakers, cutting-edge technologies, and engaging networking events. Programming includes in-depth coverage of antibody discovery, protein engineering, bispecific antibodies, emerging immunotherapies, protein aggregation, machine learning, cell and gene therapy, protein expression, purification and production.

A gatering of the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals at the leading edge of molecular engineering and therapeutic design.

This unique event brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotide and precision therapeutics throughout the drug development process.